CA3123493C - Molecules de liaison a l'antigene cd28 agonistes de ciblage de tumeurs - Google Patents
Molecules de liaison a l'antigene cd28 agonistes de ciblage de tumeursInfo
- Publication number
- CA3123493C CA3123493C CA3123493A CA3123493A CA3123493C CA 3123493 C CA3123493 C CA 3123493C CA 3123493 A CA3123493 A CA 3123493A CA 3123493 A CA3123493 A CA 3123493A CA 3123493 C CA3123493 C CA 3123493C
- Authority
- CA
- Canada
- Prior art keywords
- seq
- amino acid
- acid sequence
- antigen binding
- cdr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
La présente invention concerne des molécules de liaison à un antigène agoniste bispécifique de ciblage de tumeurs, caractérisées par une liaison monovalente à CD28, des procédés pour leur production, des compositions pharmaceutiques contenant ces anticorps, et leurs procédés d'utilisation.
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18215121 | 2018-12-21 | ||
| EP18215121.7 | 2018-12-21 | ||
| EP19187709.1 | 2019-07-23 | ||
| EP19187709 | 2019-07-23 | ||
| EP19196006 | 2019-09-06 | ||
| EP19196006.1 | 2019-09-06 | ||
| PCT/EP2019/086143 WO2020127618A1 (fr) | 2018-12-21 | 2019-12-19 | Molécules de liaison à l'antigène cd28 agonistes de ciblage de tumeurs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA3123493A1 CA3123493A1 (fr) | 2020-06-25 |
| CA3123493C true CA3123493C (fr) | 2025-11-25 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12600781B2 (en) | Tumor-targeted agonistic CD28 antigen binding molecules | |
| US20200223925A1 (en) | Tumor-targeted superagonistic cd28 antigen binding molecules | |
| US12049515B2 (en) | Agonistic CD28 antigen binding molecules targeting Her2 | |
| WO2021260064A1 (fr) | Molécules bispécifiques de liaison à l'antigène anti-cd3/anti-cd28 | |
| US20240368309A1 (en) | Agonistic cd28 antigen binding molecules targeting epcam | |
| US20220098305A1 (en) | Novel icos antibodies and tumor-targeted antigen binding molecules comprising them | |
| CA3123493C (fr) | Molecules de liaison a l'antigene cd28 agonistes de ciblage de tumeurs | |
| RU2837821C1 (ru) | Нацеленные на опухоль агонистические cd28-антигенсвязывающие молекулы | |
| RU2852151C1 (ru) | Агонистические cd28-антигенсвязывающие молекулы, нацеленные на her2 | |
| RU2808030C2 (ru) | Нацеленные на опухоль агонистические cd28-антигенсвязывающие молекулы | |
| HK40108448A (zh) | 靶向肿瘤的激动性cd28抗原结合分子 | |
| HK40128000A (zh) | 靶向肿瘤的激动性cd28抗原结合分子 | |
| HK40059019A (en) | Tumor-targeted agonistic cd28 antigen binding molecules | |
| BR112021012101B1 (pt) | Molécula de ligação ao antígeno agonístico cd28 biespecífico, composição farmacêutica e uso da molécula de ligação ao antígeno agonístico cd28 biespecífico |